The Effect of Time to Castration Resistance on Overall Survival and Success of Docetaxel Treatment in Castration Resistant Prostate Cancer Patients.

SÜER E., Hamidi N., Akpinar C., GÖKCE M. İ., GÜLPINAR Ö., Turkolmez K., ...Daha Fazla

Urology journal, cilt.16, sa.5, ss.453-457, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 5
  • Basım Tarihi: 2019
  • Doi Numarası: 10.22037/uj.v0i0.4497
  • Dergi Adı: Urology journal
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.453-457
  • Anahtar Kelimeler: castration, chemotherapy, docetaxel, prostate cancer, survival, ABIRATERONE ACETATE, DOUBLE-BLIND, MITOXANTRONE, CABAZITAXEL, PREDNISONE, THERAPY, MEN
  • Ankara Üniversitesi Adresli: Evet

Özet

Purpose: To investigate the prognostic role of time to castration resistance(TTCR) in patients who have received solely Docetaxel chemotherapy regimen(DCR) for castration resistant prostate cancer(CRPC).